Earnings intelligence
Earnings Signals
A clear read on the latest earnings surprise, its evidence, and what could invalidate the call.
SCTX
Scribe Therapeutics, Inc.FY2026 · Q2 · fast release
Waiting for enough evidence
Release facts extracted from a configured entitled source
Evidence coverage
40%
Completeness,
not win probability
- Release
- unknown
- Guidance
- unknown
- Market reaction
- —
EPS
—
Consensus -3.62 USD/share
REVENUE
1.9
Consensus 3.11 USDm
Recent signals
- FLOShort bias
EPS missed estimates by 990.1%; guidance lowered.
- NTAPLong bias
Revenue beat estimates by 10.5%; guidance raised.
- MDTLong bias
EPS beat estimates by 4.3%; Revenue beat estimates by 2.2%; guidance raised; fresh reaction +2.7%.
- BILLLong bias
Revenue beat estimates by 1.3%; guidance raised; fresh reaction +3.4%.
- NTSKLong bias
Revenue beat estimates by 2.9%; guidance raised.
- MMEDLong bias
Revenue beat estimates by 2.0%; guidance raised.
Today’s reports
Why the model sees it this way
- EPS: — reported vs -3.62 consensus · consensus comparison incomplete.
- REVENUE: 1.9 reported vs 3.11 consensus · below consensus.
- Release facts extracted from a configured entitled source
Risks & open questions
- Still missing: eps actual and estimate.
- Still missing: standardized eps surprise.
- Still missing: analyst classification.
- Still missing: fresh read only quote.
- A fresh post-release market reaction has not been captured yet.
Signal track record
ResearchCurrent verdict
Profitability is not established
No current-model directional call has resolved yet. PREVICT cannot honestly claim this signal is profitable or unprofitable.
Resolved calls
0 / 200
minimum evidence gate
Evidence audit & data status1 revisions
Revision history
- Revision 1 · fast release · abstain ·
Data pipeline
- Stream
- connected
- Screen latency p95
- Not measured
- Queue
- 0
- Last update
- official filingok ·
- official irnot configured
- public wiredelayed ·
- structured crosscheckok
- licensed transcriptnot configured
- earningscalls transcriptnot configured
- public wire:business wireok ·
- public wire:globe newswireoffline ·
- public wire:pr newswireok ·
- analyst classificationok ·
- reaction quotesdelayed ·
- transcript analysisok ·